Law360, New York (September 01, 2009) -- Abrika Pharmaceuticals Inc. has asked the court in charge of antitrust litigation against Biovail Corp. and GlaxoSmithKline PLC over the antidepressant Wellbutrin XL to let it intervene in the case to fight the direct purchaser plaintiffs' bid for documents from patent litigation Biovail brought against Abrika in Florida.
Abrika LLLP, Abrika Pharmaceuticals LLLP and Abrika Pharmaceuticals Inc. filed their motion in the U.S. District Court for the Eastern District of Pennsylvania on Tuesday....
